Literature DB >> 15760792

Propylthiouracil-induced sensorineural hearing loss associated with antineutrophil cytoplasmic antibodies.

Sriurai Thamprajamchit1, Chanchai Jariengprasert, Rajata Rajatanavin.   

Abstract

OBJECTIVE: To report the case of a young woman with Graves' disease in whom ototoxicity developed because of propylthiouracil (PTU)-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
METHODS: We present the clinical findings, pertinent laboratory data, and follow-up course of a patient with Graves' disease and bilateral sensorineural hearing loss. We also provide a literature review regarding thionamide-induced ANCA-associated vasculitis.
RESULTS: In a 22-year-old Thai woman with Graves' disease, tinnitus, hearing impairment in the left ear (with progression to the right ear), and vertigo developed after 3 years of therapy with PTU. Audiograms showed bilateral sensorineural hearing loss with cochlear lesions. She also had low-grade fever, intermittent chronic abdominal pain, weight loss, polyarthralgia, and conjunctivitis. An indirect immunofluorescence test for ANCA was positive. The hearing impairment and tinnitus were gradually reduced after PTU withdrawal and corticosteroid and azathioprine treatment. Definitive therapy by subtotal thyroidectomy was subsequently performed and yielded good results.
CONCLUSION: This rare case of PTU-induced ANCA-associated vasculitis manifested with ototoxicity in combination with systemic involvement.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15760792     DOI: 10.4158/EP.10.5.432

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  4 in total

1.  Evaluation of hearing loss in patients with Graves' disease.

Authors:  Dilek Berker; Hayriye Karabulut; Serhat Isik; Yasemin Tutuncu; Ufuk Ozuguz; Gonul Erden; Yusuf Aydin; Muharrem Dagli; Serdar Guler
Journal:  Endocrine       Date:  2011-08-11       Impact factor: 3.633

2.  Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease.

Authors:  Connie M Sears; Amee D Azad; Linus Amarikwa; Brandon H Pham; Clara J Men; Daniel N Kaplan; Jocelyn Liu; Andrew R Hoffman; Austin Swanson; Jennifer Alyono; Jennifer Y Lee; Chrysoula Dosiou; Andrea L Kossler
Journal:  Am J Ophthalmol       Date:  2022-02-25       Impact factor: 5.488

Review 3.  Endocrine Glands and Hearing: Auditory Manifestations of Various Endocrine and Metabolic Conditions.

Authors:  Kripa Elizabeth Cherian; Nitin Kapoor; Suma Susan Mathews; Thomas Vizhalil Paul
Journal:  Indian J Endocrinol Metab       Date:  2017 May-Jun

4.  Propylthiouracil-induced Otitis Media with Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Authors:  Rika Tanaka; Yasuhiro Shimojima; Hideaki Moteki; Dai Kishida; Ken-Ichi Ueno; Yoshiki Sekijima
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.